weight loss drug prescriptions semaglutide tirzepatide q3 2024 data Dynamics and Health Burden Changes with versus Major Increase in Prescribed Drugs

GLP-1 receptors are expressed not only in pancreatic beta cells but also in various tissues including the cardiovascular system, kidneys, and immune cells such as macrophages and lymphocytes

Given the limited evidence base, patients should weigh the financial commitment against the uncertain benefits and prioritise proven interventions first

doi: 10.1530/EC-18-0099 2 MollerNJorgensenJO

All the "Wolverine" protocols one reads about online are community extrapolations, not scientific data

[15] In both trials, after 72 weeks of treatment, participants who received tirzepatide at all three dose levels experienced a statistically significant reduction in body weight compared to those who received placebo, and greater proportions of participants who received tirzepatide achieved at least 5% weight reduction compared to placebo

The pill is licensed for adults with obesity (a BMI of 30 or above), or who are overweight (a BMI of 27 to 30) with at least one weight-related condition, alongside a reduced-calorie diet and more physical activity